TipRanks on MSN
Lipocine Advances Phase 3 Trial for PPD Treatment
Lipocine ( ($LPCN) ) has provided an update. Lipocine Inc. announced progress in its Phase 3 clinical trial for LPCN 1154, an oral brexanolone ...
Neurocentrx Pharma, a clinical-stage biopharmaceutical company pioneering safer, more accessible treatments for major mental health conditions, today announced the close of its seed extension funding ...
MUNICH, Germany, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Ketabon GmbH (“Ketabon” or “the Company”), a joint venture between HMNC Brain Health and Develco Pharma, announced today favorable results from its ...
OXFORD, England--(BUSINESS WIRE)--Beckley Psytech Ltd, a private, clinical-stage biotechnology company developing rapid-acting, short-duration psychedelic medicines for neuropsychiatric conditions, ...
The FDA designation expands the drug’s potential patient pool tenfold, to an estimated 13 million Americans who consider suicide annually. Clinical trials demonstrated rapid and statistically ...
Health on MSN
What Supplements Are Good for Depression?
Medically reviewed by Lindsay Cook, PharmD You may take vitamin D to help improve depression symptoms.Omega-3 fatty acids could have benefits for depression, but more research is needed.Keep in mind ...
Compass Pathways plc is poised to start the first ever phase III trial of the psychedelic drug psilocybin, after getting U.S. FDA backing for a study in treatment-resistant depression. The phase III, ...
TORONTO--(BUSINESS WIRE)-- Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback